- Investing Ideas
- Swiss Pharmaceuticals & Biotech Most Popular Stocks
Swiss Pharmaceuticals & Biotech Most Popular Stocks
Results
23
Most Popular Stocks on the market
23 companies
Roche Holding
Market Cap: CHF 295.7b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 370.40
7D
4.0%
1Y
42.5%
Novartis
Market Cap: CHF 240.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 126.76
7D
2.7%
1Y
25.2%
Lonza Group
Market Cap: CHF 41.1b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 587.80
7D
3.8%
1Y
2.6%
Galderma Group
Market Cap: CHF 39.8b
Operates as a dermatology company worldwide.
GALD
CHF 170.60
7D
0.8%
1Y
24.4%
Sandoz Group
Market Cap: CHF 31.8b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 73.38
7D
-2.0%
1Y
45.2%
Bachem Holding
Market Cap: CHF 5.7b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 75.45
7D
0.8%
1Y
14.2%
Dottikon ES Holding
Market Cap: CHF 3.8b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 272.50
7D
-2.5%
1Y
-6.5%
Siegfried Holding
Market Cap: CHF 3.3b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 75.85
7D
-2.8%
1Y
-11.7%
Tecan Group
Market Cap: CHF 2.4b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 192.70
7D
0.4%
1Y
10.6%
SKAN Group
Market Cap: CHF 1.5b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 65.20
7D
13.0%
1Y
-1.5%
PolyPeptide Group
Market Cap: CHF 1.5b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 43.95
7D
-0.1%
1Y
50.5%
Idorsia
Market Cap: CHF 1.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 5.38
7D
-8.7%
1Y
94.4%
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
CMHC
CHF 58.30
7D
2.1%
1Y
0%
Kuros Biosciences
Market Cap: CHF 839.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 21.16
7D
-1.1%
1Y
-18.2%
Basilea Pharmaceutica
Market Cap: CHF 802.5m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 64.70
7D
19.4%
1Y
38.5%
Newron Pharmaceuticals
Market Cap: CHF 253.8m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 12.20
7D
-4.2%
1Y
42.0%
Santhera Pharmaceuticals Holding
Market Cap: CHF 243.7m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 15.98
7D
0.5%
1Y
14.6%
BioVersys
Market Cap: CHF 145.5m
Researches and develops antimicrobial drugs for bacterial infections.
BIOV
CHF 24.80
7D
-6.4%
1Y
-0.4%
Molecular Partners
Market Cap: CHF 132.4m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.53
7D
3.8%
1Y
21.3%
Curatis Holding
Market Cap: CHF 105.5m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 19.90
7D
9.9%
1Y
73.0%
Xlife Sciences
Market Cap: CHF 83.8m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 14.70
7D
-8.7%
1Y
-29.3%
MindMaze Therapeutics Holding
Market Cap: CHF 25.5m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.17
7D
-26.7%
1Y
n/a
Addex Therapeutics
Market Cap: CHF 3.3m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.028
7D
-31.4%
1Y
-50.0%